OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Effectiveness of monoclonal antibody therapy for COVID-19 patients using a risk scoring system
Yoshikazu Mutoh, Takumi Umemura, Aiko Ota, et al.
Journal of Infection and Chemotherapy (2021) Vol. 28, Iss. 2, pp. 352-355
Open Access | Times Cited: 6
Yoshikazu Mutoh, Takumi Umemura, Aiko Ota, et al.
Journal of Infection and Chemotherapy (2021) Vol. 28, Iss. 2, pp. 352-355
Open Access | Times Cited: 6
Showing 6 citing articles:
Viral target and metabolism‐based rationale for combined use of recently authorized small molecule COVID‐19 medicines: Molnupiravir, nirmatrelvir, and remdesivir
Daisy Yan, Bingfang Yan
Fundamental and Clinical Pharmacology (2023) Vol. 37, Iss. 4, pp. 726-738
Open Access | Times Cited: 11
Daisy Yan, Bingfang Yan
Fundamental and Clinical Pharmacology (2023) Vol. 37, Iss. 4, pp. 726-738
Open Access | Times Cited: 11
Biologics in COVID-19 So Far: Systematic Review
Milton Arias, Henry Oliveros, Sharon Lechtig, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 7, pp. 783-783
Open Access | Times Cited: 8
Milton Arias, Henry Oliveros, Sharon Lechtig, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 7, pp. 783-783
Open Access | Times Cited: 8
Novel Therapeutic Target Critical for SARS-CoV-2 Infectivity and Induction of the Cytokine Release Syndrome
William Harless, B. M. Lewis, Bessi Qorri, et al.
Cells (2023) Vol. 12, Iss. 9, pp. 1332-1332
Open Access | Times Cited: 4
William Harless, B. M. Lewis, Bessi Qorri, et al.
Cells (2023) Vol. 12, Iss. 9, pp. 1332-1332
Open Access | Times Cited: 4
Antispike monoclonal antibodies for prevention and treatment of coronavirus disease-2019 in solid organ transplant recipients
Zachary A. Yetmar, Eric Bhaimia, Raymund R. Razonable
Current Opinion in Organ Transplantation (2022) Vol. 27, Iss. 4, pp. 269-276
Open Access | Times Cited: 6
Zachary A. Yetmar, Eric Bhaimia, Raymund R. Razonable
Current Opinion in Organ Transplantation (2022) Vol. 27, Iss. 4, pp. 269-276
Open Access | Times Cited: 6
High Anti-CoV2S Antibody Levels at Hospitalization Are Associated with Improved Survival in Patients with COVID-19 Vaccine Breakthrough Infection
Matthias Wolfgang Heinzl, Lisa Kolenchery, Michael Resl, et al.
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 23, pp. 15581-15581
Open Access | Times Cited: 5
Matthias Wolfgang Heinzl, Lisa Kolenchery, Michael Resl, et al.
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 23, pp. 15581-15581
Open Access | Times Cited: 5
The Case for Human Challenge Trials in COVID-19
George Drewett
Journal of Bioethical Inquiry (2023) Vol. 21, Iss. 1, pp. 151-165
Closed Access | Times Cited: 1
George Drewett
Journal of Bioethical Inquiry (2023) Vol. 21, Iss. 1, pp. 151-165
Closed Access | Times Cited: 1
